dc.contributor.author | Pamuk, ON | |
dc.contributor.author | Yanardag, H | |
dc.date.accessioned | 2021-03-04T19:39:54Z | |
dc.date.available | 2021-03-04T19:39:54Z | |
dc.identifier.citation | Yanardag H., Pamuk O., "Lacrimal gland involvement in sarcoidosis - The clinical features of 9 patients", SWISS MEDICAL WEEKLY, cilt.133, ss.388-391, 2003 | |
dc.identifier.issn | 1424-7860 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_90e31f7a-4c25-44fb-976e-f86cefc9e886 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/97773 | |
dc.description.abstract | Patients and Methods: Ocular disease is relatively common in sarcoidosis and can be the initial clinical manifestation in some instances. In this study, we retrospectively evaluated the clinical and demographic features of 9 (1.74%) patients with lacrimal gland (LG) involvement out of 516 sarcoidosis patients who were followed up at our centre over the preceding 36-years. In addition, the characteristics of patients with LG involvement were compared to those of other cases with eye involvement and to other sarcoidosis patients. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.title | Lacrimal gland involvement in sarcoidosis - The clinical features of 9 patients | |
dc.type | Makale | |
dc.relation.journal | SWISS MEDICAL WEEKLY | |
dc.contributor.department | , , | |
dc.identifier.volume | 133 | |
dc.identifier.startpage | 388 | |
dc.identifier.endpage | 391 | |
dc.contributor.firstauthorID | 168958 | |